North America Sterile Compounding Pharmacies Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Injectable Drugs and Infusions) and Route of Administration (Intravenous, Intramuscular, and Subcutaneous)

No. of Pages: 100    |    Report Code: TIPRE00027147    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Sterile Compounding Pharmacies Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Sterile Compounding Pharmacies Market – By Product

1.3.2        North America Sterile Compounding Pharmacies Market – By Route of Administration

1.3.3        North America Sterile Compounding Pharmacies Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Sterile Compounding Pharmacies Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America PEST Analysis

4.3         Experts Opinion

5.           North America Sterile Compounding Pharmacies Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Uptake of Personalized Medicines

5.1.2        Benefits of On-site Sterile Compounding

5.2         Market Restraints

5.2.1        Product Recalls and Stringent Regulatory Requirements

5.3         Market Opportunities

5.3.1        Development of Centralized or Regional Compounding Centers for Customized Formulation

5.4         Future Trends

5.4.1        Continued Support for Outsourcing Facilities and Manufacturing

5.5         Impact Analysis

6.           Sterile Compounding Pharmacies Market– North America Analysis

6.1         North America Sterile Compounding Pharmacies Market Revenue Forecast and Analysis

7.           North America Sterile Compounding Pharmacies Market– by Product

7.1         Overview

7.2         North America Sterile Compounding Pharmacies Market, By Product, 2021 & 2028 (%)

7.3         Injectable Drugs

7.3.1        Overview

7.3.2        Injectable Drugs: North America Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

7.4         Infusions

7.4.1        Overview

7.4.2        Infusions: North America Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

8.           North America Sterile Compounding Pharmacies Market– by Route of Administration

8.1         Overview

8.2         North America Sterile Compounding Pharmacies Market Share by Route of Administration - 2021 & 2028 (%)

8.3         Subcutaneous

8.3.1        Overview

8.3.2        Subcutaneous: North America Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

8.4         Intravenous

8.4.1        Overview

8.4.2        Intravenous: North America Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

8.5         Intramuscular

8.5.1        Overview

8.5.2        Intramuscular: North America Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

9.           North America Sterile Compounding Pharmacies Market– Country Analysis

9.1         North America: Sterile Compounding Pharmacies Market

9.1.1        Overview

9.1.3        North America: Sterile Compounding Pharmacies Market, by Country, 2021 & 2028 (%)

9.1.3.1          US: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.1.1          Overview

9.1.3.1.2          US: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.1.3          US: Sterile Compounding Pharmacies Market, by Product, 2019–2028 (US$ Million)

9.1.3.1.4          US: Sterile Compounding Pharmacies Market, by Route of Administration, 2019–2028 (US$ Million)

9.1.3.2          Canada: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.2.1          Overview

9.1.3.2.2          Canada: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.2.3          Canada: Sterile Compounding Pharmacies Market, by Product, 2019–2028 (US$ Million)

9.1.3.2.4          Canada: Sterile Compounding Pharmacies Market, by Route of Administration, 2019–2028 (US$ Million)

9.1.3.3          Mexico: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.3.1          Overview

9.1.3.3.2          Mexico: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.3.3          Mexico: Sterile Compounding Pharmacies Market, by Product, 2019–2028 (US$ Million)

9.1.3.3.4          Mexico: Sterile Compounding Pharmacies Market, by Route of Administration, 2019–2028 (US$ Million)

10.        Impact Of COVID-19 Pandemic on North America Sterile Compounding Pharmacies Market

10.1      North America: Impact Assessment of COVID-19 Pandemic

11.        Sterile Compounding Pharmacies Market–Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Fagron, Inc.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Triangle Compounding Pharmacy

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      B. Braun Melsungen AG

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Phar MEDium Healthcare Holdings, Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Fresenius Kabi AG

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Avella Specialty Pharmacy

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Pencol Compounding Pharmacy

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Pavilion Compounding Pharmacy, LLC.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Pace Pharmacy

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   SandsRx

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             North America Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 4.             Canada: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Canada Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 6.             Mexico: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Mexico Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 8.             Organic Developments in the North America Sterile Compounding Pharmacies Market

Table 9.             Inorganic Developments in the North America Sterile Compounding Pharmacies Market

Table 10.          Glossary of Terms

 


LIST OF FIGURES

Figure 1.           North America Sterile Compounding Pharmacies Market Segmentation

Figure 2.           North America Sterile Compounding Pharmacies Market, By Country

Figure 3.           North America Sterile Compounding Pharmacies Market Overview

Figure 4.           Injectable Drugs Segment Held Largest Share of Product Segment in North America Sterile Compounding Pharmacies Market

Figure 5.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Impact Analysis of Drivers and Restraints About North America Sterile Compounding Pharmacies Market

Figure 9.           North America Sterile Compounding Pharmacies Market – Revenue Forecast and Analysis – 2020- 2028

Figure 10.        North America Sterile Compounding Pharmacies Market, by Product, 2021 & 2028 (%)

Figure 11.        Injectable Drugs: North America Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Infusions: North America Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        North America Sterile Compounding Pharmacies Market Share by Route of Administration - 2021 & 2028 (%)

Figure 14.        Subcutaneous: North America Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        Intravenous: North America Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Intramuscular: North America Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17.        North America: Sterile Compounding Pharmacies Market, by Key Country – Revenue (2021) (US$ Million)

Figure 18.        North America: Sterile Compounding Pharmacies Market, by Country, 2021 & 2028 (%)

Figure 19.        US: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Canada: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Mexico: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Impact of COVID-19 Pandemic in North American Country Markets

The List of Companies - North America Sterile Compounding Pharmacies Market

  1. Avella Specialty Pharmacy
  2. B. Braun Melsungen AG
  3. Fagron, Inc.
  4. Fresenius Kabi AG
  5. Pace Pharmacy
  6. Pavilion Compounding Pharmacy, LLC.
  7. Pencol Compounding Pharmacy
  8. PharMEDium Healthcare Holdings, Inc.
  9. SandsRx
  10. Triangle Compounding Pharmacy